Ironwood Pharmaceuticals (IRWD) Gross Profit (2013 - 2020)

Ironwood Pharmaceuticals has reported Gross Profit for 7 years, with the latest figure at $115.8 million in Q4 2020.

• Quarterly Gross Profit changed 0.43% year-over-year to $115.8 million in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $386.4 million (down 4.49% YoY) and the FY2020 annual result came in at $386.4 million, down 4.49% from the prior year.
• Gross Profit grew to $115.8 million in Q4 2020 per IRWD's latest filing, from $103.5 million in the prior quarter.
• Over five years, Gross Profit peaked at $130.7 million in Q3 2019 and troughed at -$21.3 million in Q4 2018.
• A 4-year average of $76.1 million and a median of $79.2 million in 2017 frame the typical range for Gross Profit.
• The sharpest annual moves came in 2018 and 2019: Gross Profit sank 124.95% in 2018, then jumped 642.2% in 2019.
• Over 4 years, Gross Profit stood at $85.2 million in 2017, then tumbled by 124.95% to -$21.3 million in 2018, then surged by 642.2% to $115.3 million in 2019, then grew by 0.43% to $115.8 million in 2020.
• According to Business Quant data, Gross Profit over the past three periods registered $115.8 million, $103.5 million, and $89.4 million for Q4 2020, Q3 2020, and Q2 2020 respectively.